Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting neuronal lysosomal dysfunction caused by β-glucocerebrosidase deficiency with an enzyme-based brain shuttle construct
Alexandra Gehrlein, Vinod Udayar, Nadia Anastasi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22

Showing 22 citing articles:

Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects
Bin Tong, Yaoqi Ba, Zhengyang Li, et al.
Neurobiology of Disease (2024) Vol. 196, pp. 106505-106505
Open Access | Times Cited: 17
Advanced Nanoparticle Engineering for Precision Therapeutics of Brain Diseases
Muhammad Ismail, Jiayi Liu, Ningyang Wang, et al.
Biomaterials (2025) Vol. 318, pp. 123138-123138
Closed Access | Times Cited: 2
Blood–brain barrier alterations and their impact on Parkinson’s disease pathogenesis and therapy
Kristina Lau, Rebecca Kotzur, Franziska Richter
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
The SATB1‐MIR22‐GBA axis mediates glucocerebroside accumulation inducing a cellular senescence‐like phenotype in dopaminergic neurons
Taylor Russo, Benjamin Kolisnyk, B.S. Aswathy, et al.
Aging Cell (2024) Vol. 23, Iss. 4
Open Access | Times Cited: 11
Gaucher disease provides a unique window into Parkinson disease pathogenesis
Ellen Hertz, Yu Chen, Ellen Sidransky
Nature Reviews Neurology (2024) Vol. 20, Iss. 9, pp. 526-540
Closed Access | Times Cited: 11
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease
Xuxiang Zhang, Heng Wu, Beisha Tang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
The lysosomal β-glucocerebrosidase strikes mitochondria: implications for Parkinson’s therapeutics
Juan Carlos Rubilar, Tiago F. Outeiro, Andrés D. Klein
Brain (2024) Vol. 147, Iss. 8, pp. 2610-2620
Closed Access | Times Cited: 5
A plug-and-play monofunctional platform for targeted degradation of extracellular proteins and vesicles
Shasha Yao, Yi Wang, Qian Tang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistribution
Nathalie Khoury, Michelle E. Pizzo, Claire B. Discenza, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed Cells
Sha Zhu, Matthew C. Deen, Yanping Zhu, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 40
Open Access | Times Cited: 8
Development of quantitative high-throughput screening assays to identify, validate, and optimize small-molecule stabilizers of misfolded β-glucocerebrosidase with therapeutic potential for Gaucher disease and Parkinson’s disease
Darian Williams, Logan M. Glasstetter, Tiffany T. Jong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
High-throughput screening for small-molecule stabilizers of misfolded glucocerebrosidase in Gaucher disease and Parkinson’s disease
Darian Williams, Logan M. Glasstetter, Tiffany T. Jong, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 42
Open Access | Times Cited: 2
Pompe disease: Unmet needs and emerging therapies
Kelly A George, Allyson L. Anding, Arjan van der Flier, et al.
Molecular Genetics and Metabolism (2024) Vol. 143, Iss. 3, pp. 108590-108590
Closed Access | Times Cited: 2
Targeted transport of biotherapeutics at the blood-brain barrier
Torben Moos, Maj Schneider Thomsen, Annette Burkhart, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 12, pp. 1823-1838
Open Access | Times Cited: 4
Mechanisms and Methods for Evaluating Drug Delivery via Transcytosis to the Brain
Kerry Rennie, Álvaro Yogi, Willard J. Costain
AAPS introductions in the pharmaceutical sciences (2024), pp. 31-68
Closed Access | Times Cited: 1
Advanced Noninvasive Strategies for the Brain Delivery of Therapeutic Proteins and Peptides
Jiayuan Lin, Zhihua Yu, Xiaoling Gao
ACS Nano (2024) Vol. 18, Iss. 34, pp. 22752-22779
Closed Access | Times Cited: 1
New glucocerebrosidase antibodies can advance research in the field of neurodegenerative disorders
Charis Ma, Krystyna Rytel, Yu Chen, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 4, pp. 1085-1086
Open Access
Therapeutic delivery of recombinant glucocerebrosidase enzyme-containing extracellular vesicles to human cells from Gaucher disease patients
Keatdamrong Janpipatkul, Nareerat Sutjarit, Amornrat Tangprasittipap, et al.
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access
Enhancedin VivoBlood Brain Barrier Transcytosis of Macromolecular Cargo Using an Engineered pH-sensitive Mouse Transferrin Receptor Binding Nanobody
Thomas J. Esparza, Shiran Su, Caroline M. Francescutti, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Enhanced in Vivo Blood Brain Barrier Transcytosis of Macromolecular Cargo Using an Engineered pH-sensitive Mouse Transferrin Receptor Binding Nanobody
Thomas J. Esparza, Shiran Su, Caroline M. Francescutti, et al.
Research Square (Research Square) (2023)
Open Access
The SATB1-MIR22-GBA axis mediates glucocerebroside accumulation inducing a cellular senescence-like phenotype in dopaminergic neurons
Taylor Russo, Benjamin Kolisnyk, Aswathy Bs, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed Cells
Sha Zhu, Matthew C. Deen, Yanping Zhu, et al.
Angewandte Chemie (2023) Vol. 135, Iss. 40
Open Access
Page 1

Scroll to top